ATEC — Alphatec Holdings, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1350653 ·
Last close
$8.06
Market Cap
$1.24B
52W High
$13.90
52W Low
$6.82
ADV30
4,157,495
Next earnings
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 192,108,000 136,476,000 -22,056,000 -33,906,000 799,478,000 139,912,000 804,825,000
Dec 2025 212,928,000 149,491,000 -5,362,000 -21,729,000 791,208,000 160,806,000 778,782,000
Sep 2025 196,503,000 137,300,000 -9,413,000 -28,578,000 787,248,000 155,741,000 775,742,000
Jun 2025 185,544,000 129,101,000 -11,485,000 -41,144,000 790,293,000 157,063,000 766,522,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$51,561,000
Investing CF
$-61,693,000
Financing CF
$-2,515,000
CapEx
$-52,343,000
Dividends Paid
Buybacks
$-5,169,000
EPS Diluted TTM
$-0.82
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,458,349,000
Inventory
$186,027,000
Receivables
$106,379,000
ST Investments
EBIT TTM
$-75,486,000
Pretax Income TTM
$-125,288,000
Interest Exp TTM
$49,802,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$787,083,008
EBITDA
$28,404,000
Free Cash Flow
$54,572,248
Enterprise Value
$1,758,588,544
Total Cash
$139,912,000
Total Debt
$603,059,968
Shares Out
153,789,305
Trailing EPS
$-0.83
Book Value
$-0.04
ROE
ROA
-3.8%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 764,155,000 -57,966,000 -143,358,000 791,208,000 778,782,000 45,231,000
Dec 2024 611,562,000 -122,913,000 -162,123,000 775,710,000 789,879,000 -44,651,000
Dec 2023 482,262,000 -148,276,000 -186,638,000 805,208,000 727,092,000 -78,485,000
Dec 2022 350,867,000 -121,102,000 -151,293,000 520,968,000 555,635,000 -75,134,000

TTM Snapshot

Revenues TTM
$132,896,000
NetIncome TTM
$-177,816,000
OpCashFlow TTM
$0
Assets (Latest)
$146,341,000
Forward EPS
$0.58

Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $10.00 · spot: $8.06 · call volume: 50 · put volume: 234
Expected Move to 2026-06-18: ±$1.40 (17.37%) — implied range $6.66$9.46 · ATM straddle on $7.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
INSP Inspire Medical Systems, Inc. $1.21B $41.99
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. $1.27B $21.82
IRMD IRADIMED CORP $1.19B $92.94
IART INTEGRA LIFESCIENCES HOLDINGS CORP $1.18B $15.19
BLFS BIOLIFE SOLUTIONS INC $1.17B $24.03

News headlines (Yahoo Finance, 1h cache)

AppFolio And 2 Other High Growth Companies With Strong Insider Ownership
2026-05-20 11:36 · Yahoo
Alphatec Holdings (ATEC) Slid on Investors’ Reaction Towards Company and Sector Factors
2026-05-14 13:43 · Yahoo
Here’s What the Street is Saying About Alphatec Holdings (ATEC) Post Earnings
2026-05-12 21:27 · Yahoo
Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Reported, And Analysts Assigned A US$18.00 Price Target
2026-05-07 19:55 · Yahoo
Lisanti Capital Dumps $5.4 Million Alphatec Stake as Medical Device Maker Struggles
2026-05-07 16:27 · Yahoo
Alphatec Holdings, Inc. Q1 2026 Earnings Call Summary
2026-05-06 00:15 · Yahoo
This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% After Earnings
2026-05-05 22:49 · Yahoo
Alphatec Q1 Earnings Call Highlights
2026-05-05 22:23 · Yahoo
Alphatec (ATEC) Q1 2026 Earnings Transcript
2026-05-05 22:15 · Yahoo
Alphatec (ATEC) Reports Break-Even Earnings for Q1
2026-05-05 22:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.